xiaflexrems.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | XIAFLEX |
| Description | Log In / Sign Up Prescribing Information Medication Guide What is XIAFLEX XIAFLEX is approved for the treatment of adult men with Peyronie’s disease with |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 107.154.105.156 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
xiaflexrems.com Valuation
|
US$3,756,991
Last updated: 2023-05-12 20:30:07
xiaflexrems.com has Semrush global rank of 2,817,229. xiaflexrems.com has an estimated worth of US$ 3,756,991, based on its estimated Ads revenue. xiaflexrems.com receives approximately 433,499 unique visitors each day. Its web server is located in United States, with IP address 107.154.105.156. According to SiteAdvisor, xiaflexrems.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$3,756,991 |
| Daily Ads Revenue | US$3,468 |
| Monthly Ads Revenue | US$104,040 |
| Yearly Ads Revenue | US$1,248,477 |
| Daily Unique Visitors | 28,900 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| xiaflexrems.com. | A | 299 | IP: 107.154.105.156 |
| xiaflexrems.com. | A | 299 | IP: 107.154.106.156 |
| xiaflexrems.com. | NS | 14400 | NS Record: dns2.cscdns.net. |
| xiaflexrems.com. | NS | 14400 | NS Record: dns1.cscdns.net. |
HtmlToTextCheckTime:2023-05-12 20:30:07
| Log In / Sign Up Prescribing Information Medication Guide What is XIAFLEX XIAFLEX is approved for the treatment of adult men with Peyronie’s disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy. XIAFLEX should be administered by a healthcare provider experienced in the treatment of male urological diseases, who has completed required training for use of XIAFLEX in the treatment of Peyronie’s disease. What is the XIAFLEX REMS A REMS ( Risk Evaluation and Mitigation Strategy ) is a strategy to manage known or potential serious risks associated with a drug and is required by the Food and Drug Administration (FDA) to ensure that the benefits of the drug outweigh its risks. Endo Pharmaceuticals has worked with the FDA to develop the XIAFLEX REMS. The XIAFLEX REMS requires a review of educational materials, training, and certification. XIAFLEX is available for the treatment of Peyronie’s disease only through the XIAFLEX REMS. The XIAFLEX REMS |
HTTP Headers
HTTP/1.1 301 Moved Permanently Location: https://www.xiaflexrems.com/ Content-Length: 0 Connection: close HTTP/1.1 200 OK Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 212 X-Iinfo: 10-126456407-0 0NNN RT(1639958326252 18) q(0 -1 -1 0) r(0 -1) B10(4,289,0) U6 Set-Cookie: visid_incap_1719008=OP4BTFGnRTyPB1AZaeRMVDbHv2EAAAAAQUIPAAAAAABVQtb1+6vHQHGXUR7vDve0; expires=Mon, 19 Dec 2022 12:04:36 GMT; HttpOnly; path=/; Domain=.xiaflexrems.com Set-Cookie: incap_ses_78_1719008=X4ujLA8O42+8BTnG7hwVATbHv2EAAAAAwmlnmF9rusVXHJGkwkxPsA==; path=/; Domain=.xiaflexrems.com |
xiaflexrems.com Whois Information
Domain Name: XIAFLEXREMS.COM Registry Domain ID: 1714680165_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-04-16T05:15:24Z Creation Date: 2012-04-20T03:25:26Z Registry Expiry Date: 2022-04-20T03:25:26Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.CSCDNS.NET Name Server: DNS2.CSCDNS.NET DNSSEC: unsigned >>> Last update of whois database: 2021-12-23T08:41:08Z <<< |